Home
About
Overview
Sharing Data
ORCID
Help
History (44)
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.
Genome-Wide Meta-Analysis of Blood Pressure Response to ß1-Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies).
Tubercidin
Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor.
Risk-adjusted quality of care rating for diabetes: ready for prime time?
See All 44 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Risk-adjusted quality of care rating for diabetes: ready for prime time?
Risk-adjusted quality of care rating for diabetes: ready for prime time? Diabetes Care. 2000 Jul; 23(7):884-6.
View in:
PubMed
subject areas
Delivery of Health Care
Diabetes Mellitus
Hospitals, Veterans
Humans
Quality Assurance, Health Care
Risk Assessment
United States
authors with profiles
Marshall Chin